FDAnews
www.fdanews.com/articles/186674-ctti-plans-recommendations-on-investigators-decentralized-trials-and-mobile-technologies

CTTI Plans Recommendations on Investigators, Decentralized Trials and Mobile Technologies

May 4, 2018

The Clinical Trials Transformation Initiative is developing several new sets of recommendations relating to clinical trials — on the qualification of investigators, the potential legal and regulatory hurdles to decentralized trials, and obstacles to incorporating mobile technology, according to its 2017 annual report.

In the report marketing the organizations 10th anniversary, CTTI said it also aims to develop toolkits personalized to stakeholders to help with adoption of its recommendations and says it will share implementation case studies with the clinical research community to show how the resources can be applied to improve processes and outcomes.

The initiative issued five new sets of recommendations last year including: developing novel endpoints generated by mobile technology; making registries into reusable platforms for conducting clinical trials; providing for pregnancy testing in clinical trials; strengthening pediatric trials in antibacterial drug development; and strengthening the investigator site community.

View today's stories